The IPO for STR Holdings, Inc. (NYSE: STRI) is open for trading. Shares are trading at $10.92 after pricing 12,300,000 shares at $10.00 per share, below the expected range ...
ENFIELD, Conn.--(BUSINESS WIRE)-- STR Holdings, Inc. (NYSE: STRI) today announced that the initial public offering of 12,300,000 shares of its common stock has been priced at $10.00 per share. The shares began trading today on The New York Stock Exchange under the ticker symbol "STRI." The closing of the offering is expected to take place on November 12. Of the shares being sold, 3,300,000 are being offered by the Company and 9,000,000 shares are being offered by selling stockholders. In addition ...
SAN DIEGO--(BUSINESS WIRE)-- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009. "Our alliances have continued to achieve strong progress with Roche's initiation of the Phase 3 registration trial for subcutaneous Herceptin, and Baxter's completion of patient enrollment in the Phase 3 GAMMAGARD with PH20 pivotal study and the launch of Hylenex in pediatric hydration," said Jonathan Lim ...
FRAMINGHAM, Mass. and SYDNEY, Nov. 6 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN) a leading innovator and provider of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it is scheduled to make presentations at two upcoming investor conferences in November. The first presentation will be made at the Third Annual Canaccord Adams Cardiovascular ...
FT. LAUDERDALE, Fla., Nov. 5, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq: MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Lazard Capital Markets 6th Annual Healthcare Conference at The St. Regis in New York on Tuesday, November 17, 2009 at 4:40 pm EST. A webcast will be available and may be accessed by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation. About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets both its RIO(R) Robotic-Arm Interactive Orthopedic system (RIO(R)) and its proprietary RESTORIS(R) implants for minimally invasive orthopedic knee procedures. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific ...
-
Overseas Shipholding Group Commences Tender Offer for Common Units of OSG America L.P. at $10.25 in Cash Per Unit
-
Lazard Capital Maintains a 'Buy' on Visa (V); Raises PT to $86 After Meeting With Management
-
IMS Health to be Acquired by TPG and CPP Investment Board
-
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
-
Cardinal Health Reports First Quarter Results
-
Myriad Genetics to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
-
Conceptus(R) to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
Symantec to Speak at Upcoming Investor Conferences
-
Lazard Downgrades AEO, WRC, ELY, JNY, ZQK, TRLG to Hold, SKS to Sell
-
Endologix to Present at Three Upcoming Conferences
-
Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual Healthcare Conference
-
Digital River Management to Speak at the Lazard Capital Markets Technology & Media Best Ideas Investor Day
-
CED Sets Dates For Upcoming Conference Season
-
Notable Analyst Rating Changes: CSX, UNH, DF, TS Upgraded; SNDK, INTC, VALE Upgraded
-
DENTSPLY International Inc. to Present at Lazard Capital Markets' 6th Annual Healthcare Conference
-
MasterCard (MA) Q3 Profits See a Charge, But Shares Down (Update)
-
Lazard Capital Initiates Coverage on A123 Systems (AONE) with a Buy
-
SciClone Pharmaceuticals to Present at Two November Investor Conferences
-
Broadcom to Present at Upcoming Conferences
-
Juniper Networks Announces the Dates and Webcast Information of Upcoming Investor Events for November 2009
-
MannKind to Present at Upcoming Conferences
-
Michael J. Castellano, Chief Financial Officer, Lazard, to Present at Keefe, Bruyette & Woods 2009 Securities Brokerage & Market Structure Conference on November 5, 2009
-
SanDisk to Present at the Lazard Capital Markets Investor Day
-
CVS Caremark Corporation to Present at Upcoming Conferences
-
Barclays & Lazard Capital Upgrade Human Genome Sciences (HGSI)
-
Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
-
Arcadia Resources to Present at Lazard Healthcare Conference in New York
-
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
-
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased R.H. Donnelley Corporation, Announces Class Action Lawsuit and Seeks to Recover Losses
-
Websense Announces Participation in Upcoming Investor Conferences
-
Form 10-Q Lazard Group LLC For: Sep 30
-
Form 10-Q Lazard Ltd For: Sep 30
-
Gen-Probe to Webcast Two Upcoming Investor Presentations
-
HealthSouth to Present at 6th Annual Lazard Healthcare Conference
-
Lazard Capital Downgrades MAKO Surgical (MAKO) to Hold
-
ViroPharma to Present at Three November Healthcare Conferences
-
GSI Commerce to Participate in Two Investor Conferences During November
-
Achillion to Present at Three Upcoming Conferences
-
CommVault Chief Operating Officer to Address Investors at Lazard's Technology & Media Best Ideas Investor Day
-
NeurogesX to Present at Two November Conferences
-
Citrix Executives to Present at Upcoming Investor Conferences
-
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
-
Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
-
Ardea Biosciences to Present at Three Upcoming Investor Conferences
-
Halozyme to Host Third Quarter Conference Call on November 6 and Present at Two Upcoming Investor Conferences
-
Lazard Ltd (LAZ) Posts Q3 EPS of $0.41, Beats By 4c
-
Form 8-K Lazard Ltd For: Oct 28
-
Lazard Ltd Reports Third-Quarter and Nine-Month 2009 Results
-
Cyclacel Pharmaceuticals Third Quarter 2009 Financial Results Conference Call On Tuesday November 3 & Upcoming Conference Presentations
-
Lazard (LAZ) Declared a $0.125 Quarterly Dividend; 1.3% Yield
